The committee noted considerable evidence to show the effectiveness of PICO in reducing rates of surgical site infections (18 studies) and seromas (7 studies). The company did meta-analyses using a ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) ...
LONDON, Jan. 27, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce a new publication showing that its PICO Single Use Negative ...